We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Southwest Airlines
LUV
$19.2B
| $553K | ﹤0.01% |
15,265
-80,732
| -84% | -$2.53M |
|
1327
Midland States Bancorp
MSBI
$692M
| $552K | ﹤0.01% |
27,722
+1,859
| +7% | +$37.5K |
|
1328
PENN Entertainment
PENN
$2.37B
| $550K | ﹤0.01% |
22,880
-506
| -2% | -$13.5K |
|
1329
SelectQuote
SLQT
$87.6M
| $547K | ﹤0.01% |
280,526
-807,231
| -74% | -$1.36M |
|
1330
Dow Inc
DOW
$21.7B
| $546K | ﹤0.01% |
10,255
-1,416
| -12% | -$75.3K |
|
1331
Newell Brands
NWL
$2.42B
| $541K | ﹤0.01% |
62,191
| – | – |
|
1332
Adient
ADNT
$1.41B
| $541K | ﹤0.01% |
14,105
-351
| -2% | -$13K |
|
1333
BioNTech
BNTX
$24.1B
| $540K | ﹤0.01% |
5,000
+1,000
| +25% | +$112K |
|
|
LEG
1334
DELISTED
Leggett & Platt
LEG
| $537K | ﹤0.01% |
18,142
-5,940
| -25% | -$187K |
|
1335
Hilton Grand Vacations
HGV
$2.88B
| $535K | ﹤0.01% |
11,774
+978
| +9% | +$43.6K |
|
1336
Sanmina
SANM
$10.5B
| $529K | ﹤0.01% |
8,782
+8,664
| +7,342% | +$475K |
|
1337
First Solar
FSLR
$20.5B
| $529K | ﹤0.01% |
2,783
+707
| +34% | +$140K |
|
|
AZPN
1338
DELISTED
Aspen Technology Inc
AZPN
| $529K | ﹤0.01% |
3,154
-337
| -10% | -$62.6K |
|
1339
Worthington Enterprises
WOR
$2.88B
| $528K | ﹤0.01% |
12,337
+5,781
| +88% | +$214K |
|
|
MZTI
1340
The Marzetti Company
MZTI
$2.81B
| $526K | ﹤0.01% |
2,615
+497
| +23% | +$101K |
|
|
STR
1341
DELISTED
Sitio Royalties
STR
| $525K | ﹤0.01% |
20,000
| – | – |
|
|
TXNM
1342
TXNM Energy Inc
TXNM
$6.03B
| $525K | ﹤0.01% |
11,643
-896
| -7% | -$42.2K |
|
1343
Avient
AVNT
$3.75B
| $524K | ﹤0.01% |
12,815
+276
| +2% | +$10.8K |
|
1344
Silgan Holdings
SLGN
$4.08B
| $521K | ﹤0.01% |
11,108
-3,940
| -26% | -$192K |
|
1345
Credo Technology Group
CRDO
$30.4B
| $520K | ﹤0.01% |
30,000
+28,000
| +1,400% | +$333K |
|
1346
First Financial Bankshares
FFIN
$4.78B
| $520K | ﹤0.01% |
18,251
-1,481
| -8% | -$42.1K |
|
1347
CareDx
CDNA
$2.77B
| $520K | ﹤0.01% |
61,125
-99,379
| -62% | -$829K |
|
1348
Highwoods Properties
HIW
$3.39B
| $519K | ﹤0.01% |
21,725
-428
| -2% | -$9.47K |
|
1349
Cousins Properties
CUZ
$4.65B
| $519K | ﹤0.01% |
22,749
-624
| -3% | -$13.1K |
|
1350
Kennametal
KMT
$2.27B
| $518K | ﹤0.01% |
18,229
-510
| -3% | -$13.7K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.